These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24224868)

  • 21. Clinical use of profiled hemodialysis.
    Colì L; Bonomini M; La Manna G; Dalmastri V; Ursino M; Ivanovich P; Bonomini V
    Artif Organs; 1998 Sep; 22(9):724-30. PubMed ID: 9754456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of isolated ultrafiltration and isovolemic dialysis on myocardial perfusion and left ventricular function assessed with
    Assa S; Kuipers J; Ettema E; Gaillard CAJM; Krijnen WP; Hummel YM; Voors AA; van Melle JP; Westerhuis R; Willemsen A; Slart RHJA; Franssen CFM
    Am J Physiol Renal Physiol; 2018 Mar; 314(3):F445-F452. PubMed ID: 29117996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dialysis-induced regional left ventricular dysfunction is ameliorated by cooling the dialysate.
    Selby NM; Burton JO; Chesterton LJ; McIntyre CW
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1216-25. PubMed ID: 17699351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in left ventricular filling parameters before and after dialysis in patients with end stage renal disease.
    Ersbøll M; Raja AA; Warming PE; Nielsen TL; Plesner LL; Dalsgaard M; Schou M; Rydahl C; Brandi L; Iversen K
    Int J Cardiovasc Imaging; 2019 Sep; 35(9):1673-1681. PubMed ID: 31093896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships of high cardiac output with ventricular morphology, myocardial energetics, and energy costs in hemodialysis patients with preserved ejection fraction.
    Harada T; Obokata M; Kurosawa K; Sorimachi H; Yoshida K; Ishida H; Ito K; Ogawa T; Ando Y; Kurabayashi M; Negishi K
    Int J Cardiovasc Imaging; 2019 Mar; 35(3):469-479. PubMed ID: 30328027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CA 125 levels and left ventricular function in patients with end-stage renal disease on maintenance hemodialysis.
    Yilmaz H; Gürel OM; Celik HT; Sahiner E; Yildirim ME; Bilgiç MA; Bavbek N; Akcay A
    Ren Fail; 2014 Mar; 36(2):210-6. PubMed ID: 24289262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations of sensitive cardiac troponin-I with left ventricular morphology, function and prognosis in end-stage renal disease patients with preserved ejection fraction.
    Otsuka K; Nakanishi K; Shimada K; Nakamura H; Inanami H; Nishioka H; Fujimoto K; Kasayuki N; Yoshiyama M
    Heart Vessels; 2018 Nov; 33(11):1334-1342. PubMed ID: 29789900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non invasive study of left ventricular function in chronic renal failure before and after hemodialysis.
    Gilmartin JJ; Duffy BS; Finnegan P; McCready N
    Clin Nephrol; 1983 Aug; 20(2):55-60. PubMed ID: 6616976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodialysis-associated hypertension: pathophysiology and therapy.
    Hörl MP; Hörl WH
    Am J Kidney Dis; 2002 Feb; 39(2):227-44. PubMed ID: 11840363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations of Macro- and Microvascular Endothelial Dysfunction With Subclinical Ventricular Dysfunction in End-Stage Renal Disease.
    Dubin RF; Guajardo I; Ayer A; Mills C; Donovan C; Beussink L; Scherzer R; Ganz P; Shah SJ
    Hypertension; 2016 Oct; 68(4):913-20. PubMed ID: 27550915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: conventional, Doppler, and tissue Doppler echocardiographic parameters.
    Kirkpantur A; Kahraman S; Yilmaz R; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
    Artif Organs; 2005 Dec; 29(12):965-72. PubMed ID: 16305652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heart failure with preserved or reduced ejection fraction in patients treated with peritoneal dialysis.
    Wang AY; Wang M; Lam CW; Chan IH; Lui SF; Sanderson JE
    Am J Kidney Dis; 2013 Jun; 61(6):975-83. PubMed ID: 23474006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Permanent arteriovenous fistula or catheter dialysis for heart failure patients.
    Roca-Tey R
    J Vasc Access; 2016 Mar; 17 Suppl 1():S23-9. PubMed ID: 26951899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of left ventricular systolic dysfunction in pre-dialysis and dialysis patients with preserved left ventricular ejection fraction.
    Hensen LCR; Goossens K; Delgado V; Abou R; Rotmans JI; Jukema JW; Bax JJ
    Eur J Heart Fail; 2018 Mar; 20(3):560-568. PubMed ID: 29164753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.
    deFilippi C; Wasserman S; Rosanio S; Tiblier E; Sperger H; Tocchi M; Christenson R; Uretsky B; Smiley M; Gold J; Muniz H; Badalamenti J; Herzog C; Henrich W
    JAMA; 2003 Jul; 290(3):353-9. PubMed ID: 12865376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left Atrial Dysfunction in End-Stage Renal Disease Patients Treated by Hemodialysis.
    Malik J; Lachmanova J; Kudlicka J; Rocinova K; Valerianova A; Bartkova M; Tesar V
    Nephron; 2016; 133(3):169-74. PubMed ID: 27344674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble neprilysin, NT-proBNP, and growth differentiation factor-15 as biomarkers for heart failure in dialysis patients (SONGBIRD).
    Claus R; Berliner D; Bavendiek U; Vodovar N; Lichtinghagen R; David S; Patecki M; Launay JM; Bauersachs J; Haller H; Hiss M; Balzer MS
    Clin Res Cardiol; 2020 Aug; 109(8):1035-1047. PubMed ID: 32002632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure.
    Chan C; Floras JS; Miller JA; Pierratos A
    Nephrol Dial Transplant; 2002 Aug; 17(8):1518-21. PubMed ID: 12147805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.